CanDirect: Effectiveness of a Telephone-supported Depression Self-care Intervention for Cancer Survivors
CanDirect
Effectiveness of a Telephone-supported Depression Self-care Intervention for Cancer Survivors
1 other identifier
interventional
246
1 country
1
Brief Summary
Depressive symptoms are common in cancer survivors; 15% or more of cancer patients, even 1 year after diagnosis, experience depressive symptoms that can have a negative impact on their quality of life. Canadian care guidelines for cancer survivors recommend supporting the active engagement of survivors in their self-care. This study is an evaluation of the effect of a depression self-care program which includes a self-care toolkit and support in the form of regular telephone calls from a self-care coach. The toolkit contains tools that help cancer survivors:
- 1.Learn new information to better understand depression. This can help people feel that they are not alone, and that their experience is not abnormal. Better understanding a condition also helps people feel more confident in their communications with health care professionals and can make it easier to share their experience with family and friends.
- 2.Learn and practice new coping skills. This can help people feel confident that they can engage in the behaviours that have been shown to be beneficial for mood, e.g. restructuring thoughts, problem solving, and planning pleasant activities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable depression
Started Jul 2016
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 24, 2016
CompletedFirst Posted
Study publicly available on registry
September 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedFebruary 19, 2020
February 1, 2020
2.8 years
August 24, 2016
February 18, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in severity of depression symptoms: Centre for Epidemiologic Studies Depression Scale (CES-D)
Baseline, 3 months, 6 months
Secondary Outcomes (5)
Change in severity of anxiety symptoms: Hospital Anxiety and Depression Scale - Anxiety subscale (HADS-Anxiety)
Baseline, 3 months, 6 months
Change in mental and physical health-related quality of life: Short Form health survey (SF-12)
Baseline, 3 months, 6 months
Change in activation: Patient Activation Measure (PAM)
Baseline, 3 months, 6 months
Change in depression diagnosis: Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders - IV Disorders (SCID)
Baseline, 6 months
Change in use of health services: self-report
Baseline, 3 month, 6 month
Study Arms (2)
Depression Self-care Intervention (SCI)
EXPERIMENTALIntervention group participants will receive the Depression Self-Care Toolkit for Cancer Survivors and will be supported by telephone by a coach who will help to activate them, guide them through the materials, help in selecting appropriate tools, and provide positive reinforcement. Coach contacts will be made every week for 3 months followed by 3 monthly contacts, up to a maximum of 15 contacts, lasting 10-20 minutes each. The coach uses a stepped approach (i.e. educate about depression, initiate mood monitoring, determine participant's goals with respect to reducing depressive symptoms, and help with the use of specific tools). A suggested script is provided for the coach as a framework for each call. Tailoring of the SCI to different participants will be based on problems, depressive symptoms (from the PHQ-9), or concerns a participant may raise during the call.
Control group
NO INTERVENTIONMembers of both groups will continue to receive "usual care" for their depression. We will not interfere with usual care beyond recommending that participants discuss their depressive symptoms with their doctor. If participants consent, a short progress report will be send to their treating physician at the end of the study. At each follow-up, we will ask participants about specific treatment they have received for depression since entering the study (antidepressant medication initiation, discontinuation, change of dose, or psychotherapy) and use of community resources. The Intervention group will receive the Depression SCI. The Control group will receive only usual care for 6 months after randomization; they will be given the Toolkit with a single coaching call upon completion of the final interview, to ensure their access to depression treatment.
Interventions
Eligibility Criteria
You may qualify if:
- completed primary cancer treatment (surgery, radiation and/or chemotherapy) for any type of cancer (NB: patients receiving adjuvant therapies will be eligible),
- between 1-10 years post-diagnosis (as suggested by clinicians collaborating on the project),
- with moderate depressive symptoms (PHQ-9 score of 8-19).
You may not qualify if:
- metastatic disease,
- suicidal,
- moderate-severe cognitive impairment,
- unable to speak and read in English or French,
- only non-melanoma skin cancer (without any other single primary cancer),
- receiving ongoing psychological treatment at baseline (because of recent finding that this treatment may negatively modify the effectiveness of the coaching component of the intervention). NB: those who begin psychological treatment during follow-up will not be withdrawn.
- dose of antidepressant medication changed within last 6 weeks at baseline. NB: those who change dose or treatment during follow-up will not be withdrawn.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St Mary's Research Centre
Montreal, Quebec, H3T1M5, Canada
Related Publications (1)
McCusker J, Jones JM, Li M, Faria R, Yaffe MJ, Lambert SD, Ciampi A, Belzile E, de Raad M. CanDirect: Effectiveness of a Telephone-Supported Depression Self-Care Intervention for Cancer Survivors. J Clin Oncol. 2021 Apr 1;39(10):1150-1161. doi: 10.1200/JCO.20.01802. Epub 2021 Feb 8.
PMID: 33555912DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Emerita and Full Professor Post-Retirement
Study Record Dates
First Submitted
August 24, 2016
First Posted
September 7, 2016
Study Start
July 1, 2016
Primary Completion
April 1, 2019
Study Completion
June 1, 2019
Last Updated
February 19, 2020
Record last verified: 2020-02